Febustat

Febuxostat (80mg)
Price: ₹320 - ₹380 for 15 tablets (80mg)
Mfr: Sun Pharmaceutical Industries Ltd. | Form: Tablet

📋 Clinical Overview

Febuxostat is a potent, selective, non-purine xanthine oxidase inhibitor used for the long-term management of hyperuricemia in patients with gout. It is a first-line urate-lowering therapy (ULT) in India, particularly for patients intolerant to allopurinol or with renal impairment. It works by reducing serum uric acid (sUA) production.

💊 Dosage & Administration

Adult: Recommended starting dose is 40mg once daily. May be increased to 80mg once daily if sUA is not below 6 mg/dL after 2 weeks with 40mg dose.

Note: Administer orally, with or without food. Tablet should be swallowed whole with a glass of water. Maintain adequate hydration (at least 2 liters of fluid per day).

⚠️ Contraindications

  • Hypersensitivity to febuxostat or any excipient
  • Patients being treated with azathioprine, mercaptopurine, or theophylline (due to risk of severe toxicity)

🔬 Mechanism of Action

Febuxostat is a potent, non-purine selective inhibitor of xanthine oxidase (XO), the enzyme responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid. By inhibiting XO, it reduces the production of uric acid, thereby lowering serum uric acid concentrations.

🤕 Side Effects

  • Liver function abnormalities (increased transaminases)
  • Nausea
  • Headache
  • Rash
  • Acute gout flares (especially during initiation)

🤰 Special Populations

Pregnancy: Category C. Animal studies have shown fetal toxicity. There are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.

Driving: Febuxostat has no or negligible influence on the ability to drive and use machines. However, patients who experience dizziness should be cautious.

🔄 Drug Interactions

AzathioprineIncreased levels of azathioprine leading to severe myelosuppression and pancytopenia.Contraindicated
MercaptopurineIncreased levels of mercaptopurine leading to severe myelosuppression and pancytopenia.Contraindicated
TheophyllineIncreased theophylline levels, risk of toxicity (nausea, seizures, arrhythmias).Contraindicated
DidanosinePotential increased risk of didanosine toxicity; avoid concomitant use.Major
NSAIDs (e.g., Naproxen, Diclofenac)Increased risk of NSAID-associated renal impairment; monitor renal function.Moderate
ColchicineNo significant PK interaction, but commonly co-administered for gout flare prophylaxis.Minor

🔁 Alternatives to Febustat

Same composition (Febuxostat (80mg)), different brands:

Febutaz 80 Febuxo Febutaz Uricoz